Bookmark Article
Boehringer Ingelheim partners with MEDS to enhance the ‘Access to Healthcare’ program in Kenya, offering subsidized type 2 diabetes and hypertension medications to eligible patients, reducing financial burdens and improving accessibility to life-saving treatments. Through strategic collaborations, the initiative aims to expand healthcare capacity, raise awareness, and provide equitable healthcare access for underserved communities, aligning with Boehringer Ingelheim’s commitment to sustainable healthcare solutions and long-term impact on non-communicable diseases. The partnership signifies a step towards a healthier, more resilient healthcare system, delivering hope and transforming lives in Kenya for generations to come.
Full Article
